Advancing Risk Assessment of Intermediate Risk Prostate Cancer Patients.

Drachenberg, Darrel; Awe, Julius A; Rangel Pozzo, Aline; Saranchuk, Jeff; Mai, Sabine

Drachenberg, Darrel; Awe, Julius A; Rangel Pozzo, Aline; Saranchuk, Jeff; Mai, Sabine.

Afiliação

Drachenberg D; Manitoba Prostate Center, Cancer Care Manitoba, Section of Urology, Department of Surgery, University of Manitoba, Winnipeg, MB R3E 0V9, Canada. drach13@mymts.net.
Awe JA; University of Manitoba, Cell Biology, Research Institute of Hematology and Oncology, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada. d4mostcts@yahoo.com.
Rangel Pozzo A; University of Manitoba, Cell Biology, Research Institute of Hematology and Oncology, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada. Aline.RangelPozzo@umanitoba.ca.
Saranchuk J; Manitoba Prostate Center, Cancer Care Manitoba, Section of Urology, Department of Surgery, University of Manitoba, Winnipeg, MB R3E 0V9, Canada. JSaranchuk@exchange.hsc.mb.ca.
Mai S; University of Manitoba, Cell Biology, Research Institute of Hematology and Oncology, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada. sabine.mai@umanitoba.ca.

Cancers (Basel) ; 11(6)2019 Jun 20.

Article em En | MEDLINE | ID: mdl-31226731

Palavras-chave

3D nucleus; Gleason 7; circulating tumor cells; intermediate risk prostate cancer; quantitative 3D telomere analysis; three-dimensional (3D) imaging

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google